Pediatric cancer recurrence poses a significant challenge for families and healthcare professionals alike, particularly in cases involving brain tumors like gliomas.Recent advancements in pediatric oncology have sparked hope, as researchers at Mass General Brigham have developed an AI predictive tool that vastly improves glioma recurrence prediction.